Informações:
Falhas:
ID
21149
Descrição
Comparison of IPX054, Immediate-Release Carbidopa-Levodopa, and Controlled-Release Carbidopa-Levodopa in Subjects With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00279825
Link
https://clinicaltrials.gov/show/NCT00279825
Palavras-chave
Versões (1)
- 11/04/2017 11/04/2017 -
Transferido a
11 de abril de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Idiopathic Parkinson's Disease NCT00279825
Eligibility Idiopathic Parkinson's Disease NCT00279825
- StudyEvent: Eligibility
Similar models
Eligibility Idiopathic Parkinson's Disease NCT00279825
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Parkinson Disease
Item
diagnosed with idiopathic parkinson's disease.
boolean
C0030567 (UMLS CUI [1])
Carbidopa / Levodopa Immediate Release | Carbidopa / Levodopa Controlled Release | Levodopa Dose
Item
currently being treated with immediate-release or controlled-release carbidopa-levodopa and not requiring more than 200 mg levodopa per dose.
boolean
C0353697 (UMLS CUI [1,1])
C1708470 (UMLS CUI [1,2])
C0353697 (UMLS CUI [2,1])
C1707506 (UMLS CUI [2,2])
C0023570 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C1708470 (UMLS CUI [1,2])
C0353697 (UMLS CUI [2,1])
C1707506 (UMLS CUI [2,2])
C0023570 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Wearing off effect Pharmaceutical Preparations Dosage
Item
must experience "wearing off" between doses of medication.
boolean
C1504539 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Atypical Parkinson Disease
Item
diagnosed with atypical parkinsonism.
boolean
C1868596 (UMLS CUI [1])
Carbidopa + levodopa allergy | Carbidopa / Levodopa Absent response to treatment
Item
allergic or non-responsive to previous carbidopa-levodopa therapy.
boolean
C0570732 (UMLS CUI [1])
C0353697 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
C0353697 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
Angle Closure Glaucoma | Glaucoma, Open-Angle
Item
active or history of narrow-angle or wide-angle glaucoma.
boolean
C0017605 (UMLS CUI [1])
C0017612 (UMLS CUI [2])
C0017612 (UMLS CUI [2])
Seizures | Epilepsy | Anticonvulsants
Item
history of seizure or epilepsy, or is currently taking an anti-convulsant for treatment of seizures.
boolean
C0036572 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
Antipsychotic Agents | Antipsychotic Agents Atypical
Item
treatment with any neuroleptic agent, including atypical neuroleptics, within the previous 12 months.
boolean
C0040615 (UMLS CUI [1])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
Dopamine Antagonists
Item
treatment with any dopaminergic blocking agent within the previous 3 months.
boolean
C0242702 (UMLS CUI [1])